Archive for July, 2010
(GPRO) Gen-Probe’s Earnings Report Leaps Ahead of Forecast
Diagnostic product maker Gen-Probe Inc. (GPRO) announced second-quarter fiscal 2010 adjusted earnings of 52 cents per share, exceeding the Zacks Consensus Estimate of 49 cents and the year-ago earnings of 45 cents. Net income soared 42% year-over-year to $28.1 million (or 57...
31Jul2010 | vitalstocks | 0 comments | Continued(MRK) Pharma Merger Mania is Heating Up
by Marc Lichtenfeld, Healthcare Expert Wednesday, July 28, 2010: Issue #1311 In the cellphone world, it’s all about “apps.” In the oil and natural gas industries, it’s all about supplies. And in the healthcare sector, it’s all about pills. Lots and lots of pills. Blue...
31Jul2010 | InvestmentU | 0 comments | Continued(AEP) American Electric Power Company Second Quarter 2010 Results Soar
American Electric Power Company Inc. (AEP) reported strong second quarter fiscal 2010 results. In the reported quarter, the company eclipsed the Zacks Consensus Estimate of 69 cents by 5 cents with EPS of 74 cents. The company’s results also climbed from the year-ago quarterly...
31Jul2010 | vitalstocks | 0 comments | Continued(IBM) International Business Machines Acquires Storwize
International Business Machines Corp. (IBM) has announced to acquire Storwize, a privately held company, for an undisclosed sum. The acquisition, expected to close in the third quarter of 2010, is expected to boost IBM’s storage capacity. Marlborough, Massachusetts based Storwize...
30Jul2010 | vitalstocks | 0 comments | Continued(ALK) Alaska Air Group – Quarterly Earnings Beat The Street
Alaska Air Group, Inc. (ALK) is once again pressuring its all-time high after reporting excellent Q2 results on July 22 that saw income double from last year. With the current-year estimate pegged at $6.59, a 168% growth projection from last year, analaysts are looking for a...
30Jul2010 | vitalstocks | 0 comments | Continued(GDP) Second Quarter Gross Domestic Product Growth
In the second quarter (2Q) Gross Domestic Product (GDP) grew at a rate of 2.4%, which was slightly less than the 2.5% consensus expectation, although the expectations had been moving down over the last week or so. However, the first quarter was revised sharply higher to an increase...
30Jul2010 | vitalstocks | 0 comments | Continued(ZION) Zions Bancorporation Unloads CDO Risks
On Wednesday, Zions Bancorporation ( ZION ) entered into a total return swap (TRS) deal with Deutsche Bank AG (DB) to lessen credit risks for certain securities in its portfolio. Through this arrangement, the company could unload risks from $1.16 billion portfolio of collateralized...
30Jul2010 | vitalstocks | 0 comments | Continued(TOT) TOTAL S.A. Second Quarter 2010 Earnings Beat Estimates
Integrated oil and gas company TOTAL S.A. (TOT) reported its second-quarter 2010 operating earnings of $1.68 per share (€1.32 per share) versus the Zacks Consensus Estimate of $1.60 per share. The operating earnings of the company reflected a growth of 60% from $1.05 (€0.77...
30Jul2010 | vitalstocks | 0 comments | Continued(COV) Covidien Beats The Street by a Nickel
Ireland-based healthcare product maker Covidien plc (COV) reported third-quarter fiscal 2010 results with adjusted (excluding one-time items such as restructuring charges and tax-related adjustments) earnings per share of 85 cents beating the Zacks Consensus Estimate of 80 cents...
30Jul2010 | vitalstocks | 0 comments | Continued(RDSA) Royal Dutch Shell PLC Boosted by Volumes – Cost Cuts
Europe’s largest oil company Royal Dutch Shell PLC (RDSA) reported strong second quarter 2010 results, buoyed by a robust operating environment, production growth and cost cutting initiatives. Earnings per ADR (on a current cost of supplies basis), excluding one-time items...
30Jul2010 | vitalstocks | 0 comments | Continued(ASTM) Aastrom Biosciences Analyst Initiates Coverage at Neutral
We are initiating coverage of Aastrom Biosciences (ASTM) with a Neutral rating and $2.50 price target. Aastrom is pioneering the research effort on adult stem cells for therapeutic applications, specifically for the treatment of cardiovascular diseases such as critical limb ischemia...
30Jul2010 | vitalstocks | 0 comments | Continued(V) Visa Earnings Report Beats The Street on Strong Top Line
Visa Inc.‘s (V) fiscal third-quarter earnings of 97 cents per share were substantially ahead of the Zacks Consensus Estimate of 93 cents. Visa’s GAAP net income for the quarter came in at $716 million, marginally down 1.8% from $729 million in the year-ago quarter....
30Jul2010 | vitalstocks | 0 comments | Continued(BRCM) Broadcom Reports Solid 2010 Second Quarter
Leading chipmaker Broadcom Corporation (BRCM) reported solid results for the second quarter of 2010, which beat both management and the Zacks estimates. Broadcom generated revenues of $1.604 billion in the second quarter of 2010, up 54.3% year over year and up 9.7% sequentially....
29Jul2010 | vitalstocks | 0 comments | Continued(WYN) Wyndham Worldwide Tops Earnings Expectations – Raises Outlook
Wyndham Worldwide Corp. (WYN) recorded second-quarter 2010 earnings of $95 million or 51 cents per share, which was well ahead of the Zacks Consensus Estimate of 41 cents and the company’s previous guidance of 38 cents to 42 cents. The increment was driven by better-than-expected...
29Jul2010 | vitalstocks | 0 comments | Continued(CSX) CSX Corporation – Bull of the Day
We are upgrading our recommendation on CSX Corporation (CSX) to Outperform from Neutral based on the solid second-quarter results and an improving outlook along with overall volume gains in various commodity businesses. The company’s second-quarter results surpassed the...
29Jul2010 | vitalstocks | 0 comments | Continued(FCN) FTI Consulting – Bear of the Day
We are downgrading our recommendation on FTI Consulting (FCN) to Underperform from Neutral as the company trimmed its fiscal year 2010 outlook. The revised outlook is due to dramatic deceleration expected in Corporate Finance and Restructuring, less-than expected recovery in...
29Jul2010 | vitalstocks | 0 comments | Continued(MDCO) Medicines Company Tops Street Estimates
The Medicines Co. (MDCO) reported a second-quarter profit of 27 cents per share Incorporatedluding the impact of stock-based compensation expense. Second quarter profit was well above the Zacks Consensus Estimate of 23 cents and the year-ago earnings of 8 cents. Performance was...
29Jul2010 | vitalstocks | 0 comments | Continued(C) Blinder-Zandi Paper Explores Why the Recession Ended
In the wake of the collapse of Lehman Brothers, the related near-failure of Citigroup (C) and the shotgun weddings of J.P. Morgan (JPM) and Washington Mutual, Bank of America (BAC) with Merrill Lynch, and Wells Fargo (WFC) with Wachovia, there was an extraordinary policy response...
29Jul2010 | vitalstocks | 0 comments | Continued(VIV) Vivo Participacoes’ Earnings Matches Estimates – Profit Swells
Vivo Participacoes (VIV), the largest wireless operator in Brazil , reported second-quarter earnings per ADS of 33 cents, in line with the Zacks Consensus Estimate. However, net income surged 29.9% year over year to R$236 million ($132 million) on the back of higher revenues...
29Jul2010 | vitalstocks | 0 comments | Continued(AKAM) Akamai Technologies’ Earnings Miss Expectations – Shares Plunge
Akamai Technologies Inc. (AKAM) reported second quarter 2010 earnings of 23 cents, missing the Zacks Consensus Estimate of 24 cents. Shares plunged more than 11% in morning trade on the Nasdaq. Earnings including stock based compensation but excluding onetime items increased...
29Jul2010 | vitalstocks | 0 comments | Continued(BMC) BMC Software First Quarter 2011 Shows Topline Grows
BMC Software (BMC) reported first quarter 2011 earnings per share of 52 cents, missing the Zacks Consensus Estimate of 56 cents by 7.14%. The company delivered revenue of $461.0 million, below the Zacks Consensus revenue estimate of $474.0 million. Revenue Revenue of $461.0 million...
29Jul2010 | vitalstocks | 0 comments | Continued(BA) U.S. New Orders for Durable Goods Slightly Below Expectations
Except for one little detail, the consensus of economists were right on target with their expectations for New Orders for Durable Goods, both in total and excluding the extremely volatile transportation equipment segment. That one little detail was a minus sign. In total, new...
29Jul2010 | vitalstocks | 0 comments | Continued(ISRG) Intuitive Surgical Second Quarter 2010 Earnings Scorecard
Intuitive Surgical (ISRG) reported favorable second-quarter 2010 results on July 21, 2010. Earnings per share (excluding one-time items) came in at $2.19, beating the Zacks Consensus Estimate of $2.05 and the year-ago figure of $1.62. Second Quarter Review Total revenue at Intuitive...
29Jul2010 | vitalstocks | 0 comments | ContinuedJul 28: Crude Inventories – Economic Highlights
Crude inventories increased by 7.3 million barrels, for the week ending July 23, from the previous week to 360.8 million barrels and were above the upper limit of the average range for that time of year. U.S. crude oil refinery inputs averaged 15.5 million barrels per day during...
29Jul2010 | vitalstocks | 0 comments | Continued(DB) Deutsche Bank AG’s Second Quarter Profit Grows
Deutsche Bank AG (DB) reported a second quarter net income of €1.2 billion ($1.5 billion) or €1.75 a share, up from €1.1 billion or €1.64 per share a year earlier. While the company experienced a substantial drop in revenues from investment banking, this was more than...
29Jul2010 | vitalstocks | 0 comments | Continued(LMT) Aerospace and Defense Review – July 2010 – Industry Outlook
OVERVIEW The growth of the Aerospace and Defense industry depends largely on the spending outlook of defense departments, with the U.S. defense budget as the primary driver. The U.S is world’s largest aerospace and defense market, home to the world’s largest military budget,...
29Jul2010 | vitalstocks | 0 comments | Continued(S) Sprint-Nextel Second Quarter 2010 Earnings Beat – Grows Subscribers
Sprint Nextel (S), the third-largest U.S. wireless carrier, reported second-quarter 2010 adjusted net loss per share of 15 cents, which surpassed the Zacks Consensus Estimate of a net loss of 19 cents. Adjusted earnings excluded a one-time tax related to non-cash charge of $302...
28Jul2010 | vitalstocks | 0 comments | Continued(WLP) WellPoint Earnings Beat – Raises Outlook
On July 28, 2010, WellPoint Inc. (WLP) reported its second-quarter income from continuing operations of $702.8 million or $1.67 per share, surpassing the Zacks Consensus Estimate of $1.56. This also compares favorably with the income of $731.5 million or earnings of $1.50 in...
28Jul2010 | vitalstocks | 0 comments | Continued(CEPH) Cephalon Second Quarter 2010 Earnings Report Beats The Street
Cephalon Inc. (CEPH) delivered another strong quarter with second quarter earnings coming in at $2.05 per share, six cents above the Zacks Consensus Estimate and well above the year-ago earnings of $1.44 per share. We note that the Zacks Consensus Estimate had been revised recently...
28Jul2010 | vitalstocks | 0 comments | Continued(MRK) Big Pharma Has a Big Problem and Merger Mania is Heating Up
by Marc Lichtenfeld, Healthcare Expert Wednesday, July 28, 2010: Issue #1311 In the cellphone world, it’s all about “apps.” In the oil and natural gas industries, it’s all about supplies. And in the healthcare sector, it’s all about pills. Lots and lots of pills. Blue...
28Jul2010 | InvestmentU | 0 comments | Continued